XPMag
XPMag is a novel magnetic nanoparticles formulation dedicated to gene transfection in organotypic cultures of explant by “Reverse Magnetofection”.
“Reverse Magnetofection” provides a novel and non-toxic strategy for nucleic acids (DNA & siRNA) based gene therapy in the retina that can be translated to a wide variety of organ explants.
XPMag associated with Reverse Magnetofection allows the delivery of nucleic acids (NA) up to the deepest explant layers.
The magnetic force, delivered by a specific magnetic plate, guides and concentrates complexes of NA and XPMag magnetic nanoparticles from the culture media to the tissue. This novel method of transfection associating XPMag and Reverse Magnetofection is fully biocompatible and does induce neither apoptosis nor inflammatory reactions.
XPMag transfection reagent main benefits:
- Low nucleic acid amount - minimized toxicity
- High level of nucleic acid compaction
- Easy and straightforward protocol
- Compatible with any type of explant
Sizes:
-
XP00250: 250 µL of XPMag reagent
-
XP00500: 500 µL of XPMag reagent
-
KXP0250: XPMag Starting Kit - 250 µL of XPMAg reagent + Super Magnetic Plate
Storage: -20°C
Shipping Conditions: Room temperature
- This reagent needs to be used with a magnetic plate
Please log in or register to see the prices for your country
Request a sample
Catalog number | Unit Size | Price excl tax | Quantity / Buy |
KXP0250 |
Starting Kit
|
$794.00
|
|
XP00500 |
500 µL
|
$492.00
|
|
XP00250 |
250 µL
|
$271.00
|
|
Citation database
NAME | MOLECULE VECTOR | PRODUCT | REFERENCE | |
661W | siRNA | XPMag | Bassetto M. Bioconjug Chem. 2021 Jun 16;32(6):1078-1093. | |
661W | siRNA | XPMag | Sen M. Pharmaceutics . 2021 Feb 6;13(2):225. | |
Ex vivo: Retinal Explant | siRNA | XPMag | Bassetto M. Methods Cell Biol . 2023:176:199-216 | |
Ex vivo: retro-orbital injection | DNA | XPMag | Cao B. Front. Mol. Biosci. 2024(11) doi.org/10.3389/fmolb.2024.1369000 | |
Ex vivo: Retinal Explant | siRNA | XPMag | Bassetto M. Bioconjug Chem. 2021 Jun 16;32(6):1078-1093. | |
Ex vivo: Retinal Explant | siRNA | XPMag | Sen M. Pharmaceutics . 2021 Feb 6;13(2):225. |
Related products